Two studies find Botox injections help reduce nighttime teeth grinding

May 1, 2012 by Bob Yirka report
Botox

(Medical Xpress) -- Two groups working independently have found that patients who suffer from nighttime teeth grinding, a condition known as nocturnal bruxism, found relief after being injected in their temple and jaw muscles with Botox. Both groups reported on their findings at this year’s American Academy of Neurology meeting.

Many people grind their teeth at night when they are asleep, though some may be unaware of doing so. It’s the degree that matters. Some grind slightly and experience no negative consequences other than annoying their sleeping partner. Other’s however experience much more serious consequences such as teeth problems, jaw and facial pain and headaches. There is currently no known cure for the condition and treatment usually consists of issuing patients mouth guards which do protect the teeth, but don’t alleviate pain or headaches. Patients with severe symptoms clearly need something better and that is why researchers have started looking into the therapeutic possibilities of botulinum toxin, more commonly known as Botox; the very same material used for cosmetic purposes.

In the first study, a team from the University of Texas Health Science Center in Houston, injected 23 people who suffered from severe bruxism. Thirteen got Botox while ten received a placebo. Four weeks later all of participants were tested to see what impact, if any, the injections had had on their and quality of sleep.

Testing results were measured in two ways, via polysomnography and by reports from the patients themselves which also included comments by sleep partners.

Polysomnography is a rigorous set of tests that have been developed for sleep studies with many parameters involved to determine the quality of sleep people experience and also to account for such problems as headaches, pain, or other situations that arise due to sleep issues. In the Houston study, the results of the Polysomnography, called a polysomnogram, were averaged together with numbers given by patients to self-assess their quality of sleep. Taken together the team found the average numbers jumping from 47.3 for bruxism patients to 64.5 after receiving Botox injections. The numbers for the placebo patients didn’t change. In addition, the team found that numbers for pain experienced increased as well, from 44.2 to 65.0 (higher means less pain). Overall, the team says, the results indicated that injecting Botox provided significant relief for all of the patients who received it, while the only side effects were slight changes in appearance for some when smiling.

In the second study, doctors at the Henry Ford Medical Center in Detroit, injected four patients who were experiencing severe bruxism following head injuries, with Botox and reported at the conference that all four showed relief from the condition without any noticeable adverse side effects.

Both groups are careful to point out that much more robust studies will need to be undertaken with the results published in a medical journal before can be claimed to be a true therapy for bruxism. On the other hand, since can already be administered for other reasons, there is nothing stopping doctors from giving patients suffering from bruxism injections right away to try to help them.

Explore further: Mayo Clinic finds botox eases painful spinal headaches

Related Stories

Mayo Clinic finds botox eases painful spinal headaches

April 14, 2011
A Mayo Clinic case study finds Botox may offer new hope to patients suffering disabling low cerebrospinal fluid headaches. The successful treatment also offers new insight into Botox and headache treatment generally. The ...

Botox injections associated with only modest benefit for chronic migraine and daily headaches

April 24, 2012
Although botulinum toxin A ("Botox") injections are U.S. Food and Drug Administration approved for preventive treatment for chronic migraines, a review and analysis of previous studies finds a small to modest benefit for ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.